These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 12020188)
21. Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem? Balaban M; Stanrić V; Rincić G; Ledinsky M; Grbac L; Stancić N; Tomasić H Acta Clin Croat; 2010 Dec; 49(4):469-77. PubMed ID: 21830460 [TBL] [Abstract][Full Text] [Related]
22. Acute physical exercise is safe in patients with primary antiphospholipid syndrome with exclusive venous thrombosis and under oral anticoagulation with warfarin. Garcia CB; Seguro LP; Perandini LA; de Sá Pinto AL; Lima FR; Negrão CE; Bonfa E; Borba EF Rheumatol Int; 2014 Dec; 34(12):1737-41. PubMed ID: 24825252 [TBL] [Abstract][Full Text] [Related]
23. [Warfarin in the treatment of antiphospholipid syndrome]. Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075 [TBL] [Abstract][Full Text] [Related]
24. Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications. ten Berg JM; Hutten BA; Kelder JC; Verheugt FW; Plokker HW Circulation; 2001 Apr; 103(16):2042-7. PubMed ID: 11319192 [TBL] [Abstract][Full Text] [Related]
25. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis. Krnic-Barrie S; O'Connor CR; Looney SW; Pierangeli SS; Harris EN Arch Intern Med; 1997 Oct; 157(18):2101-8. PubMed ID: 9382667 [TBL] [Abstract][Full Text] [Related]
26. Simultaneous intrahepatic and subgaleal hemorrhage in antiphospholipid syndrome following anticoagulation therapy. Park IC; Baek YH; Han SY; Lee SW; Chung WT; Lee SW; Kang SH; Cho DS World J Gastroenterol; 2013 Oct; 19(38):6494-9. PubMed ID: 24151371 [TBL] [Abstract][Full Text] [Related]
27. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome. Malec K; Góralczyk T; Undas A Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of anticoagulation in patients with antiphospholipid syndrome. Horner KE; Phillips BB; Newkirk E; McDanel DL; Kaboli P Am J Health Syst Pharm; 2008 May; 65(10):964-7. PubMed ID: 18463346 [TBL] [Abstract][Full Text] [Related]
32. Severe hemorrhagic corpus luteum complicating anticoagulation in antiphospholipid syndrome. Yamakami LY; de Araujo DB; Silva CA; Baracat EC; de Carvalho JF Lupus; 2011 Apr; 20(5):523-6. PubMed ID: 21138983 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome. Ohnishi N; Fujieda Y; Hisada R; Nakamura H; Kato M; Oku K; Bohgaki T; Amengual O; Yasuda S; Atsumi T Rheumatology (Oxford); 2019 Jun; 58(6):969-974. PubMed ID: 30508199 [TBL] [Abstract][Full Text] [Related]
34. Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature. Dufrost V; Risse J; Zuily S; Wahl D Curr Rheumatol Rep; 2016 Dec; 18(12):74. PubMed ID: 27812956 [TBL] [Abstract][Full Text] [Related]
35. Direct oral anticoagulants versus warfarin in patients with antiphospholipid syndrome: A meta-analysis of randomized controlled trials. Lee YH; Song GG Lupus; 2022 Oct; 31(11):1335-1343. PubMed ID: 35968627 [TBL] [Abstract][Full Text] [Related]
36. Increased warfarin consumption and residual fibrin turnover in thrombotic patients with primary antiphospholipid syndrome. Ames PR; Margaglione M; Ciampa A; Colaizzo D; Ferrara F; Iannaccone L; Vincenzobrancaccio Thromb Res; 2011 Jun; 127(6):595-9. PubMed ID: 21371740 [TBL] [Abstract][Full Text] [Related]
37. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Ruiz-Irastorza G; Hunt BJ; Khamashta MA Arthritis Rheum; 2007 Dec; 57(8):1487-95. PubMed ID: 18050167 [TBL] [Abstract][Full Text] [Related]
38. Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort. Tan BE; Thong BY; Shivananda S; Han WW; Chng HH Lupus; 2009 Jul; 18(8):752-8. PubMed ID: 19502274 [TBL] [Abstract][Full Text] [Related]
39. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Palareti G; Leali N; Coccheri S; Poggi M; Manotti C; D'Angelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berrettini M; Musolesi S Lancet; 1996 Aug; 348(9025):423-8. PubMed ID: 8709780 [TBL] [Abstract][Full Text] [Related]
40. Massive ovarian haemorrhage complicating oral anticoagulation in the antiphospholipid syndrome: a report of three cases. Crétel E; Cacoub P; Huong DL; Gompel A; Amoura Z; Piette JC Lupus; 1999; 8(6):482-5. PubMed ID: 10483020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]